The impact of substitution treatment in prisons—A literature review

Stallwitz, Anke; Stöver, Heino

doi:10.1016/j.drugpo.2006.11.015

Cited by 94 publications

(71 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Methadone maintenance in the community reduces heroin and polydrug use, mortality and crime [7][8][9][10] . Until recently, prison-based methadone programmes were scarce, but they are now being increasingly implemented in criminal justice settings [11] .…”

Section: Introductionmentioning

confidence: 99%

Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release

et al. 2010

View full text Add to dashboard Cite

Background:After prison release, offenders with heroin use problems are at high risk of relapse and overdose death. There is a particular need for treatments that can be initiated in prison and continued after release into the community. Methadone maintenance treatment has been shown to reduce heroin use, criminality and mortality. Naltrexone implant treatment has not previously been evaluated in prison settings. Methods:This study compares the effects of naltrexone implants and methadone treatment on heroin and other illicit drug use, and criminality among heroin-dependent inmates after release from prison. Results:Forty-six volunteers were randomly allocated to naltrexone implants or methadone before release. Intention-to-treat analyses showed reductions in both groups in frequency of use of heroin and benzodiazepines, as well as criminality, 6 months after prison release. Conclusions:Naltrexone implants may be a valuable treatment option in prison settings.

show abstract

Section: Introductionmentioning

confidence: 99%

Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release

et al. 2010

View full text Add to dashboard Cite

show abstract

“…In Germany, compared to its neighboring countries, this treatment was introduced relatively late. However, in the last five years, the number of patients in substitution treatment has increased significantly to more than 70,000 patients, which marks an increase of 50%, meaning that one third to one half of the estimated opiate [28] und der Post-Entlassungsmortalität aufgrund rückfallbedingter Überdosierungen [29].…”

Section: Practice Problems and Perspectives Of Opioid Substitution Tmentioning

confidence: 99%

Praxis, Probleme und Perspektiven der Substitutionsbehandlung Opioidabhängiger in Deutschland

Michels

Sander²,

Stöver

2009

Bundesgesundheitsbl.

Self Cite

View full text Add to dashboard Cite

Opioid dependency is a complex and chronically relapsing disease with high risks of morbidity and mortality. Frequent relapses and in most of the cases a long process of maturing out characterize this disease. Opioid substitution programs with methadone, buprenorphine and other opioids are a suitable intervention and form the first choice in the treatment of this disease. In Germany, compared to its neighboring countries, this treatment was introduced relatively late. However, in the last five years, the number of patients in substitution treatment has increased significantly to more than 70,000 patients, which marks an increase of 50%, meaning that one third to one half of the estimated opiate users are being reached. Despite the widely acknowledged success with respect to the improvement of the quality of life, survival rates, and accessibility of the target groups for ongoing treatments of drug-related diseases (such as HIV/HCV infections), opioid substitution treatment is still discussed controversially. In this contribution, problems in the areas of service provision, juristic, social, health and research policies are discussed and possibilities of increasing the access and quality of this treatment are introduced.

show abstract

“…(e) The original evaluation studies must have the following method characteristics: there must be at least one control or comparison group; the control group should be exposed to either no intervention or minimal treatment, and the control group must not include dropouts (people who had previously participated in the treatment program but later left it). Some systematic reviews which did not meet one or more of these criteria could not be included in this study (e.g., Adams, Leukefeld, & Peden, 2008;Bright & Martire, 2013;Egli, Pina, Skovbo Christensen, Aebi, & Killias, 2009;Ferri, Davoli, & Perucci, 2011;Fiestas & Ponce, 2012;Hedrich et al, 2011;Holloway, Bennett, & Farrington, 2005Koehler, Humphreys, Akoensi, Sanchez de Ribera, & Lösel, 2014;Larney, 2010;Mazerolle, Soole, & Rombouts, 2007;McMurran, 2006;Minozzi et al, 2011;Mitchell, Wilson, Eggers, & MacKenzie, 2012;Perry, 2006;Perry, Darwin, et al, 2009;Perry et al, 2013;Perry et al, 2015aPerry et al, , 2015bPerry, Newman, et al, 2009;Tripodi, Bledsoe, Kim, & Bender, 2011;Smedslund et al, 2011;Smith, Gates, & Foxcroft, 2006;Stallwitz & Stöver, 2007).…”

Section: Methodsmentioning

confidence: 99%

Effectiveness of Prison-based Drug Treatment Programs: A Systematic Review of Meta-analyses

Topçuoğlu¹

2016

addicta

View full text Add to dashboard Cite

Objectives: Drawing upon existing meta-analytic reviews, this paper aims to systematically review the state of research on the effects of prison-based drug treatment programs on drug use and recidivism after imprisonment. Method: A systematic search was carried out through the Cochrane Library, the Campbell Collaboration Library of Systematic Reviews and Google scholar. Results: Based on the eligibility criteria set forth, three meta-analytic studies on the effects of prison-based drug treatment programs on drug use and recidivism were retrieved. All three meta-analyses consistently point to the positive effects of therapeutic communities both on drug use and recidivism. Findings regarding the positive effects of other incarcerationbased drug treatment programs (e.g., counselling, narcotic maintenance programs, etc.) are less clear.Limitations as well as implications of the findings for research, policy and practice in Turkey are discussed.

show abstract

The impact of substitution treatment in prisons—A literature review

Cited by 94 publications

References 36 publications

Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release

Naltrexone Implants Compared to Methadone: Outcomes Six Months after Prison Release

Praxis, Probleme und Perspektiven der Substitutionsbehandlung Opioidabhängiger in Deutschland

Effectiveness of Prison-based Drug Treatment Programs: A Systematic Review of Meta-analyses

Contact Info

Product

Resources

About